Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

Jean‐Yves Blay, Margaret von Mehren, Patrick Schöffski et al.|The Lancet Oncology|2020

Cited by 406